DK1971361T3 - Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom - Google Patents

Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom

Info

Publication number
DK1971361T3
DK1971361T3 DK06847924.5T DK06847924T DK1971361T3 DK 1971361 T3 DK1971361 T3 DK 1971361T3 DK 06847924 T DK06847924 T DK 06847924T DK 1971361 T3 DK1971361 T3 DK 1971361T3
Authority
DK
Denmark
Prior art keywords
glycoforms
enhanced
treatment
metabolic syndrome
stimulating hormone
Prior art date
Application number
DK06847924.5T
Other languages
English (en)
Inventor
James D Kelly
Original Assignee
James D Kelly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James D Kelly filed Critical James D Kelly
Application granted granted Critical
Publication of DK1971361T3 publication Critical patent/DK1971361T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK06847924.5T 2005-12-23 2006-12-21 Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom DK1971361T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75379805P 2005-12-23 2005-12-23
PCT/US2006/048820 WO2007075906A2 (en) 2005-12-23 2006-12-21 Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome

Publications (1)

Publication Number Publication Date
DK1971361T3 true DK1971361T3 (da) 2014-09-08

Family

ID=38218620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06847924.5T DK1971361T3 (da) 2005-12-23 2006-12-21 Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom

Country Status (7)

Country Link
US (1) US9333241B2 (da)
EP (1) EP1971361B1 (da)
JP (1) JP5727693B2 (da)
AU (1) AU2006331619B2 (da)
CA (1) CA2631948A1 (da)
DK (1) DK1971361T3 (da)
WO (1) WO2007075906A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2631948A1 (en) 2005-12-23 2007-07-05 James D. Kelly Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
CA2741030A1 (en) 2008-10-20 2010-04-29 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
US9206154B2 (en) 2010-04-08 2015-12-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inverse agonists and neutral antagonists for the TSH receptor
KR101789509B1 (ko) * 2015-11-05 2017-10-26 주식회사 프로젠 재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 생산 방법
CN115975056B (zh) * 2023-02-07 2023-12-01 徐州医科大学 利用天然蛋白tsh作为抗原结合位点构建靶向tshr的car-t细胞

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0228604A3 (en) 1985-12-11 1988-10-12 Sloan-Kettering Institute For Cancer Research Isolation of a gene encoding human thyrotropin beta subunit
JP2001517445A (ja) 1997-09-22 2001-10-09 ユニヴァーシティ オブ メリーランド，ボルチモア 甲状腺刺激ホルモンの突然変異体およびそれに基づく方法
EP2264177B1 (en) 1998-12-09 2015-09-30 Phyton Holdings, LLC Glycoproteins having human-type glycosylation
US7514239B2 (en) 2000-03-28 2009-04-07 Amgen Inc. Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
US20030219786A1 (en) 2000-08-11 2003-11-27 Applied Research Systems Ars Holding N.V. Novel glycoproteins and methods of use thereof
JP2004521952A (ja) 2001-07-13 2004-07-22 ザイモジェネティクス，インコーポレイティド 脂肪分解を誘発するためのコルチコトロフ−誘導の糖タンパク質ホルモンの使用
CA2487924A1 (en) 2002-06-10 2003-12-18 Zymogenetics, Inc. Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
US20040138116A1 (en) * 2002-08-30 2004-07-15 Vincent Geenen Tolerogenic approach for type 1 diabetes
US20050096264A1 (en) 2003-02-25 2005-05-05 Macdonald Lynn Methods for treating obesity and related conditions with glycoprotein hormone beta family hormones
CA2517896A1 (en) 2003-03-05 2004-09-16 Zymogenetics, Inc. Use of thyroid-stimulating hormone to induce lipolysis
EP1682576A1 (en) 2003-11-06 2006-07-26 Compugen Ltd. Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
US20050171017A1 (en) 2003-12-05 2005-08-04 Kelly James D. Methods for treating inflammation using thyroid stimulating hormone
US20050250185A1 (en) 2003-12-12 2005-11-10 Murphy Andrew J OGH fusion polypeptides and therapeutic uses thereof
US8431355B2 (en) * 2004-02-04 2013-04-30 Universite De Provence Aix-Marseille 1 Process for screening glycoform-specific antibodies
EP1734990A1 (en) * 2004-03-05 2006-12-27 ZymoGenetics, Inc. Use of corticotroph-derived glycoprotein hormone to treat liver steatosis
CA2631948A1 (en) 2005-12-23 2007-07-05 James D. Kelly Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome

Also Published As

Publication number Publication date
US9333241B2 (en) 2016-05-10
WO2007075906A2 (en) 2007-07-05
JP2009525264A (ja) 2009-07-09
AU2006331619B2 (en) 2012-12-20
EP1971361A2 (en) 2008-09-24
EP1971361B1 (en) 2014-06-04
CA2631948A1 (en) 2007-07-05
US20100210512A1 (en) 2010-08-19
WO2007075906A3 (en) 2009-09-03
EP1971361A4 (en) 2010-08-18
AU2006331619A1 (en) 2007-07-05
JP5727693B2 (ja) 2015-06-03

Similar Documents

Publication Publication Date Title
DK1844070T3 (da) Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet
DK2046819T3 (da) Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
DK2478896T3 (da) Brudsikre doseringsforme med forsinket frigivelse
DK1919878T3 (da) Pyridazinonderivater som thyroidhormonreceptoragonister
EP1728801A4 (en) SUBTYP OF A HUMANIZED ANTIBODY AGAINST THE INTERLEUKIN-6 RECEPTOR
DK2129654T3 (da) Antagonister af glucagonreceptoren
TWI370135B (en) Analogs of ghrelin substituted at the n-terminal
DK2038423T3 (da) Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet
NO20084339L (no) Stabiliserte polypeptidsammensetninger
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
PL2018184T3 (pl) Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego
IS8596A (is) Mótefni gegn CD154
DK2227243T3 (da) Farmaceutisk sammensætning til behandling af obesitet relaterede sygdomme, omfattende et insulinotropisk peptidkonjugat
BRPI0820535A8 (pt) composições farmacêuticas contendo insulina e um peptídeo insulinotrópico
DK3453387T3 (da) Doseringsplan til en s1p-receptoragonist
DK1711465T3 (da) Hydroisoindolin-tachykinikreceptorantagonister
DK2160221T3 (da) Cykliske peptid-CXCR4-antagonister
BRPI0809931A2 (pt) Antagonistas do receptor do hormônio liberador de gonadotrofina e métodos relacionados com o mesmo
DK1959988T3 (da) Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder
DK2035447T3 (da) Polypeptid
BR112013002096A2 (pt) compostos de agonistas de receptor glp-1 possuindo regiões estabilizadas
DK1942967T3 (da) Fremgangsmåde til dosering af medikamenter
EP2078037A4 (en) HETERODIMERS / OLIGOMERS OF THE RECEPTOR FOR THE THYROTROPIN RELEASING HORMONE OF THE OREXIN RECEPTOR
DK1776133T3 (da) Peptid-vasopressin-receptor-agonister
DK1986642T3 (da) Kombination af alfa-2-receptoragonist (clonidin) og et antimuscarinmiddel (oxybutynin) til behandling af sialorrhoea